Key result
Doxorubicin-induced diastolic dysfunction is linked to a >5-fold increase in myocardial lactate levels.
Why the study?
Diastolic dysfunction tends to prevail in all patterns of chronic heart failure, and a lack of effective therapy requires further investigation into metabolic processes in cardiomyocytes.
Does doxorubicin-induced diastolic dysfunction alter energy metabolism and titin phosphorylation in an animal model?
Does doxorubicin-induced diastolic dysfunction alter energy metabolism and titin phosphorylation in an animal model?
Doxorubicin-induced diastolic dysfunction in an animal model is associated with increased anaerobic metabolism and titin phosphorylation, facilitating LV filling.
Answers are grounded in this paper and cite their sources.
Supports metabolic and titin involvement in animal doxorubicin model; hypothesis-generating, should not change practice.
RELEVANCE: Diastolic dysfunction occurring at hypertension, obesity, diabetes, or treatment with doxorubicin tends to prevail in all patterns of chronic heart failure. Lack of effective therapy forces to look more into the metabolic processes in cardiomyocytes. OBJECTIVE: Assess energy metabolism in cardiomyocytes and changes in titin, a giant myofibril protein that responsible for their elasticity. MATERIAL AND METHODS: The study model was cardiomyopathy occurring after the 4-week administration of doxorubicin (2 mg/kg weekly). Diastolic dysfunction was identified by echocardiography and catheterization with the simultaneous measurement of pressure and volume of the left ventricle (LV). RESULTS: The levels of adenine nucleotides and phosphocreatine in the heart of animals treated with doxorubicin differed little from the normal values, but lactate levels were increased manifold. A 50% increase in the level of titin phosphorylation was detected, which correlated (r = 0,94) with a nearly twofold increase in the share of a more elastic N2BA-isoform of this protein. CONCLUSION: This form of diastolic dysfunction involves the activation of anaerobic metabolism and increased stretching of myofibrils facilitating LV filling.
No takes yet. Share an insight, caveat, or question.
Lakomkin et al. (2020) studied Doxorubicin-induced cardiomyopathy / Diastolic dysfunction (n=30). Doxorubicin vs. Saline was evaluated on Myocardial lactate level (μmol/g dry weight) (p=<0.05). Doxorubicin-induced diastolic dysfunction was associated with a more than 5-fold increase in myocardial lactate levels and a 50% increase in titin phosphorylation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: